Tag: Epiminder
Cochlear-backed Aussie innovator raises $16m to test seizure epilepsy monitoring device
Australian medical device innovator Epiminder has raised $16 million to expand its ongoing UMPIRE (sUb-scalp Monitoring ePileptic seIzuREs) clinical trial for Minder®, an ultra-long-term ambulatory electroencephalography...
Featured Article
The economic forces driving manufacturing’s next cycle
Australia’s manufacturing sector entered 2026 with improving momentum, but renewed global disruption is again testing resilience across the industry.
